THIS
NOTE HAS NOT
BEEN REGISTERED UNDER
THE SECURITIES ACT
OF 1933, AS AMENDED
(THE "ACT"), OR
UNDER THE SECURITIES
LAWS OF CERTAIN
STATES. THESE SECURITIES ARE
SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE
AND MAY NOT
BE TRANSFERRED OR
RESOLD EXCEPT AS
PERMITTED UNDER
THE ACT AND
THE APPLICABLE STATE
SECURITIES LAWS, PURSUANT
TO REGISTRATION OR EXEMPTION
THEREFROM. LENDERS SHOULD
BE AWARE THAT THEY MAY BE REQUIRED
TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN
OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE
EFFECT THAT ANY PROPOSED
TRANSFER OR RESALE IS
IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.


 


LG
CAPITAL FUNDING,
LLC


COLLATERALIZED
SECURED PROMISSORY NOTE


 


 





	$56,000.00	Brooklyn,
                                         NY

                                              June
                                         23, 2016










		1.	Principal
                                         and Interest



 


FOR
VALUE RECEIVED, LG
Capital Funding, LLC,
a New York
Limited Liability Company (the
"Company") hereby absolutely
and unconditionally promises
to pay to
Rich Pharmaceuticals, Inc. (the
“Lender"), or order,
the principal amount
of Fifty Six
Thousand Dollars ($56,000.00) no
later than September
10, 2016, unless
the Lender does
not meet the
“current information requirements”
required under Rule
144 of the
Securities Act of
1933, as amended,
in which case the
Company may declare
the offsetting note
issued by the
Lender on the
same date herewith to
be in Default
(as defined in
that note) and
cross cancel its
payment obligations under
this Note as well
as the Lenders
payment obligations under
the offsetting note.
This Full Recourse
Note shall bear simple interest at the rate of 8%.


 


		2.	Repayments
                                         and Prepayments;
                                         Security.



 


a.                  
All principal under
this Note shall
be due and
payable no later
than September 10, 2016,
unless the Lender
does not meet
the “current information
requirements” required under
Rule 144 of
the Securities Act
of 1933, as
amended, in which
case the Company
may declare the offsetting
note issued by
the Lender on
the same date
herewith to be
in Default (as
defined in that note)
and cross cancel
its payment obligations
under this Note
as well as
the Lenders payment obligations
under the offsetting
note.


 


b.                 
The Company may
pay this Note
at any time.
This note may
not be assigned by
the Lender, except
by operation of
law.


 


c.                  
This Note shall
initially be secured
by the pledge
of the $56,000
8% convertible promissory note
issued to the
Company by the
Lender on even
date herewith (the “Lender
 Note”).  The 
Company  may  exchange
 this  collateral 
for  other  collateral 
with  an appraised value of
at least $56,000.00,
by providing 3
days prior written
notice to the
Lender. If the
Lender does not
object to
the substitution
of collateral in
that 3 day
period, such substitution
of collateral shall
be deemed to
have been accepted
by the Lender. Notwithstanding the
foregoing, an exchange of
collateral for $56,000.00 in cash
shall not require the approval of the Lender. All collateral shall be retained by New
Venture Attorneys, P.C., which shall act
as the escrow
agent for the collateral
for the benefit of the
Lender. The Company may not effect any conversions under the Lender Note until
it has made full cash payment for the portion of the Lender Note being converted.



    	 	1	 



     


    




 


		3.	Events
                                         of Default;
                                         Acceleration.



 


a.                  
The principal amount
of this Note
is subject to
prepayment in whole
or in part
upon the occurrence and
during the continuance
of any of
the following events
(each, an “Event
of Default”): the initiation
of any bankruptcy,
insolvency, moratorium, receivership
or reorganization by or
against the Company,
or a general
assignment of assets
by the Company
for the benefit
of creditors. Upon the
occurrence of any
Event of Default,
the entire unpaid
principal balance of
this Note and all
of the unpaid
interest accrued thereon
shall be immediately
due and payable.
The Company may offset amounts
due to the Lender
under this Note by similar
amounts that may be due to
the Company by
the Lender resulting
from breaches under
the Lender Note.


 


b.                 
No remedy herein
conferred upon the
Lender is intended
to be exclusive
of any other remedy
and each and
every remedy shall
be cumulative and
in addition to
every other remedy hereunder,
now or hereafter
existing at law
or in equity
or otherwise. The
Company accepts and agrees
that this Note
is a full
recourse note and
that the Holder
may exercise any
and all remedies available
to it under
law.


 


		4.	Notices.



 


a.                    
All notices, reports
and other communications
required or permitted
hereunder shall be in
writing and may
be delivered in
person, by telecopy
with written confirmation,
overnight delivery service or
U.S. mail, in
which event it
may be mailed
by first-class, certified
or registered, postage prepaid,
addressed (i) if
to a Lender,
at such Lender’s
address as the
Lender shall have furnished
the Company in
writing and (ii)
if to the
Company at such
address as the
Company shall have furnished
the Lender(s) in
writing.


 


b.                 
Each such notice,
report or other
communication shall for
all purposes under
this Note be treated
as effective or
having been given
when delivered if
delivered personally or,
if sent by mail,
at the earlier
of its receipt
or 72 hours
after the same
has been deposited
in a regularly maintained
receptacle for the
deposit of the
United States mail,
addressed and mailed
as aforesaid, or, if
sent by electronic
communication with confirmation,
upon the delivery
of electronic communication.



    	 	2	 



     


    




 


		5.	Miscellaneous.









a.                    
Neither this Note
nor any provisions
hereof may be
changed, waived, discharged
or terminated orally, but
only by a
signed statement in
writing.


 


b.                 
No failure or
delay by the
Lender to exercise
any right hereunder
shall operate as
a waiver thereof, nor
shall any single
or partial exercise
of any right,
power or privilege
preclude any other right,
power or privilege.
The provisions of
this Note are
severable and if
any one provision hereof
shall be held
invalid or unenforceable
in whole or
in part in
any jurisdiction, such
invalidity or unenforceability shall
affect only such
provision in such
jurisdiction. This Note
expresses the entire understanding
of the parties
with respect to
the transactions contemplated
hereby. The Company and every endorser and guarantor of this Note regardless
of the time, order or place of signing hereby waives presentment, demand,
protest and notice of every kind,
and assents to any extension or postponement of the time for payment or any other indulgence,
to any substitution, exchange or release of collateral, and to the addition or release of any other party or person primarily
or secondarily liable.


 


c.                  
If Lender retains an attorney
for collection of this Note, or
if any suit or
proceeding is brought for the
recovery of all,
or any part
of, or for
protection of the
indebtedness respected by
this Note, then the
Company agrees to
pay all costs
and expenses of
the suit or
proceeding, or any
appeal thereof, incurred by
the Lender, including
without limitation, reasonable
attorneys' fees.


 


d.                 
This Note shall
for all purposes
be governed by,
and construed in
accordance with the laws
of the State
of New York
(without reference to
conflict of laws).


 


e.                  
This Note shall
be binding upon
the Company's successors
and assigns, and
shall inure to the
benefit of the
Lender's successors and
assigns.




    	 	3	 



     


    

 





IN
WITNESS WHEREOF, the
Company has caused
this Note to
be executed by
its duly authorized officer
to take effect
as of the
date first hereinabove
written.


 


 


LG
CAPITAL FUNDING,
LLC


 


 


By:
/s/ Joseph Lerman


Title:
Manager


 


 


 APPROVED:


 


RICH
PHARMACEUTICALS, INC.


 


 By:
/s/ Ben Chang


 Title:
CEO



    	 	4